KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to -$3.7 million.

  • Emergent BioSolutions' Other Non Operating Income fell 11689.5% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.0 million, marking a year-over-year increase of 12014.93%. This contributed to the annual value of $12.5 million for FY2024, which is 4044.94% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Other Non Operating Income stood at -$3.7 million, which was down 11689.5% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Other Non Operating Income ranged from a high of $69.7 million in Q1 2025 and a low of -$13.4 million during Q3 2022
  • For the 5-year period, Emergent BioSolutions' Other Non Operating Income averaged around $3.6 million, with its median value being -$2.4 million (2021).
  • As far as peak fluctuations go, Emergent BioSolutions' Other Non Operating Income plummeted by 45833.33% in 2022, and later skyrocketed by 215000.0% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Other Non Operating Income (Quarter) stood at -$900000.0 in 2021, then surged by 844.44% to $6.7 million in 2022, then surged by 64.18% to $11.0 million in 2023, then plummeted by 130.0% to -$3.3 million in 2024, then decreased by 12.12% to -$3.7 million in 2025.
  • Its Other Non Operating Income was -$3.7 million in Q3 2025, compared to -$3.7 million in Q2 2025 and $69.7 million in Q1 2025.